by McDermott + Bull | Jun 25, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article, Technology Article
The JPM Q1 2024 MedTech Licensing and Venture report highlights the first quarter of 2024 and shows promising developments in the MedTech investment landscape. There are indications of a potential recovery and growth compared to previous years. Can we be so lucky?...
by McDermott + Bull | May 22, 2024 | Article, Garrett Lipus, Garrett Lipus Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Lipus
Healthcare PE activity in Q1 2024 remained subdued, marking a continuation of the downturn seen in 2023. PE sponsors announced or closed an estimated 158 deals in the quarter, maintaining the sluggish pace of 2023. Despite a somewhat more optimistic narrative around...
by McDermott + Bull | May 16, 2024 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article
A few weeks ago, McDermott + Bull Interim Leaders and I hosted a small breakfast for C-Level executives in the life sciences sector. Simon Arkell, CEO and Co-Founder of Ryght AI, joined us as our keynote speaker to share his thoughts and insights on AI and its impact...
by McDermott + Bull | Nov 29, 2023 | Article, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article
Recently, my colleague Mark McConnell and I hosted a breakfast meeting with around 40 local C-Suite executives within the life sciences sector. Paul LaViollette, Managing Partner and Chief Operating Officer of SV Health Investors, joined us from Boston to share his...
by McDermott + Bull | Mar 13, 2023 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
A CONVERSATION WITH RENOWNED VASCULAR SURGEON, DR. FRANK J. VEITH As one of America’s most celebrated surgeons, Dr. Frank Veith’s career was anything but conventional – he’s worked undercover for the CIA, attempted to make Vascular Surgery an independent specialty,...
by McDermott + Bull | Feb 16, 2023 | Article, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article
In 2022, we saw a significant increase in the number of deals by private equity and venture capital firms within the life sciences, medical, and healthcare sectors. This all points toward positive growth, but the biggest challenge PE and VC firms face is seeing a...
